CLRB
Price
$6.79
Change
-$1.15 (-14.48%)
Updated
Jun 26, 01:13 PM (EDT)
Capitalization
14.39M
53 days until earnings call
QTTB
Price
$1.52
Change
-$0.07 (-4.40%)
Updated
Jun 26, 01:03 PM (EDT)
Capitalization
19.03M
Interact to see
Advertisement

CLRB vs QTTB

Header iconCLRB vs QTTB Comparison
Open Charts CLRB vs QTTBBanner chart's image
Cellectar Biosciences
Price$6.79
Change-$1.15 (-14.48%)
Volume$1.33K
Capitalization14.39M
Q32 Bio
Price$1.52
Change-$0.07 (-4.40%)
Volume$147
Capitalization19.03M
CLRB vs QTTB Comparison Chart in %
Loading...
CLRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLRB vs. QTTB commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLRB is a Hold and QTTB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (CLRB: $7.94 vs. QTTB: $1.56)
Brand notoriety: CLRB and QTTB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLRB: 50% vs. QTTB: 31%
Market capitalization -- CLRB: $14.39M vs. QTTB: $19.03M
CLRB [@Biotechnology] is valued at $14.39M. QTTB’s [@Biotechnology] market capitalization is $19.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLRB’s FA Score shows that 0 FA rating(s) are green whileQTTB’s FA Score has 0 green FA rating(s).

  • CLRB’s FA Score: 0 green, 5 red.
  • QTTB’s FA Score: 0 green, 5 red.
According to our system of comparison, QTTB is a better buy in the long-term than CLRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLRB’s TA Score shows that 4 TA indicator(s) are bullish while QTTB’s TA Score has 3 bullish TA indicator(s).

  • CLRB’s TA Score: 4 bullish, 6 bearish.
  • QTTB’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CLRB is a better buy in the short-term than QTTB.

Price Growth

CLRB (@Biotechnology) experienced а -27.59% price change this week, while QTTB (@Biotechnology) price change was -2.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.78%. For the same industry, the average monthly price growth was +31.36%, and the average quarterly price growth was +15.04%.

Reported Earning Dates

CLRB is expected to report earnings on Aug 18, 2025.

QTTB is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+1.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QTTB($19M) has a higher market cap than CLRB($14.4M). CLRB YTD gains are higher at: -11.483 vs. QTTB (-54.651). QTTB has higher annual earnings (EBITDA): -40.39M vs. CLRB (-45.92M). CLRB has less debt than QTTB: CLRB (474K) vs QTTB (18.8M). CLRB (0) and QTTB (0) have equivalent revenues.
CLRBQTTBCLRB / QTTB
Capitalization14.4M19M76%
EBITDA-45.92M-40.39M114%
Gain YTD-11.483-54.65121%
P/E RatioN/AN/A-
Revenue00-
Total CashN/A65.5M-
Total Debt474K18.8M3%
FUNDAMENTALS RATINGS
CLRB vs QTTB: Fundamental Ratings
CLRB
QTTB
OUTLOOK RATING
1..100
9278
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
47
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5791
P/E GROWTH RATING
1..100
73100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QTTB's Valuation (47) in the null industry is in the same range as CLRB (58) in the Biotechnology industry. This means that QTTB’s stock grew similarly to CLRB’s over the last 12 months.

QTTB's Profit vs Risk Rating (100) in the null industry is in the same range as CLRB (100) in the Biotechnology industry. This means that QTTB’s stock grew similarly to CLRB’s over the last 12 months.

QTTB's SMR Rating (100) in the null industry is in the same range as CLRB (100) in the Biotechnology industry. This means that QTTB’s stock grew similarly to CLRB’s over the last 12 months.

CLRB's Price Growth Rating (57) in the Biotechnology industry is somewhat better than the same rating for QTTB (91) in the null industry. This means that CLRB’s stock grew somewhat faster than QTTB’s over the last 12 months.

CLRB's P/E Growth Rating (73) in the Biotechnology industry is in the same range as QTTB (100) in the null industry. This means that CLRB’s stock grew similarly to QTTB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLRBQTTB
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 23 days ago
84%
Declines
ODDS (%)
Bearish Trend 10 days ago
85%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CLRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MHUA0.430.02
+4.18%
Meihua International Medical Technologies Co Ltd
TWI9.220.15
+1.65%
Titan International
PHLT3.850.04
+1.05%
Performant Healthcare Inc
LYV146.19-1.59
-1.08%
Live Nation Entertainment
ALRM57.00-0.80
-1.38%
Alarm.com Holdings

CLRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLRB has been closely correlated with QTTB. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CLRB jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRB
1D Price
Change %
CLRB100%
-18.14%
QTTB - CLRB
73%
Closely correlated
-1.89%
IBRX - CLRB
42%
Loosely correlated
-1.08%
ADCT - CLRB
39%
Loosely correlated
-3.16%
ANAB - CLRB
37%
Loosely correlated
-0.34%
CELC - CLRB
37%
Loosely correlated
-2.47%
More